HTPEP-001

N/A

Report date: 2025/01/15 11:09:41
NME

Base Information

Drug NameHTPEP-001
Drug Alias NameHTPEP-001
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTransforming growth factor beta inhibitors
TargetsTransforming growth factor beta
Therapy Area/IndicationsSolid tumoursIdiopathic Pulmonary FibrosisPulmonary Fibrosis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Huitai Biomedical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Huitai Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursIdiopathic Pulmonary FibrosisPulmonary Fibrosis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank